维普中文期刊产品整合服务
148篇 您的检索式:作者名="DANNULL"
    题名 作者 年代 出处 被引量
1Tumor vaccines:from gene therapy to dendritic cells the emerging frontier 显示文摘Vieweg J Dannull J 2003Uro Clin North Am2003,30,3:1
2Tumor vaccines:from gene therapy to dendritie cells-the emerging frontier显示文摘Vieweg J Dannull J 2003Urol Clin North Am2003,30,:1
3Prostate stem cell antigen is optomising candidate for immuno therapy of advanced prostate cancer 显示文摘Dannul LJ Diener PA Prikler L 2000Cancer Res2000,60,19:1
4Telomerase mRNA transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer显示文摘Su Z Dannull J Yang B K 2005J Immunol2005,174,6:1
5Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells显示文摘Su Z Dannull J Heiser A 2003Cancer Res2003,63,9:1
6Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer显示文摘DANNULL J DIENER PA PRIKLER L 2000Cancer Res2000,60,19:1
7Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells 显示文摘Dannull J Su Z Rizzieri D Yang BK Coleman D Yancey D 2005Clin Invest2005,115,12:1
8Enhancement of vaccine-medi- ated antitumor immunity in cancer patients after depletion of regula- tory T cells显示文摘Dannull J Su Z Rizzieri D 2005J Clin Invest2005,115,12:1
9Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors 显示文摘Heiser A Coleman D Dannull J 2002J Clin Invest2002,109,:1
10Enhancement of vaccine mediated antitumor immunity in cancer patients after depletion of regulatory T cells显示文摘Dannull J Su Z Rizzieri D 2005J Clin Invest2005,115,12:1
11Enhancement of vaccine - mediated ant tumor immunity in cancer patients after depletion of regulatory T cells显示文摘Dannul J Su Z Rizzieri D 2005J Clin Invest2005,115,12:1
12from gene therapy to dendritic cells the emerging frontier 显示文摘Vieweg J Dannull J Appella E 2003Urol Clin North Am2003,30,:1
13Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer显示文摘Dannull J Diener PA Prikler L 2000Cancer Res2000,60,19:1
14Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors显示文摘Heiser A Coleman D Dannull J 2002J Clin Invest2002,109,3:1
15Enhancementofvaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells显示文摘DANNULL J SU Z RIZZIERI D 0,,12:1
16Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer显示文摘Dannull J Diener PA Prikler L 2000Cancer Res2000,60,19:1
17Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells 显示文摘Dannull J Su Z Rizzieri D 2005J Clin Invest2005,115,12:1
18Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer显示文摘Dannull J Diener PA Prikler L 2000Cancer Res2000,60,19:1
19Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells显示文摘Su Z Dannull J Heiser A 2003Cancer Res2003,63,:1
20Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors显示文摘Axel Heiser Doris Coleman Jens Dannull 2002Clin Invest2002,109,3:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费